Skip to content

Effect of PRP on the treatment of vitiligo

Comparison of the effect of PRP and hair transplantation with hair transplantation alone in the treatment of vitiligo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015120725407N1
Enrollment
22
Registered
2016-01-29
Start date
2015-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. disorders of pigmentation

Interventions

Intervention 1: follicular grafts would be transplanted With FIT technique throughout some lesions. After 5 days dressings would be removed and PRP would be injected on hair transplanted and non hair
the dose would be increased 15% at each treatment interval. Intervention 2: In the lesions of the other site of the body follicular grafts would be transplanted With FIT technique throughout the lesio
the dose increased 15% at each treatment interval.
Treatment - Surgery
Treatment - Other
follicular grafts would be transplanted With FIT technique throughout some lesions. After 5 days dressings would be removed and PRP would be injected on hair transplanted and non hair transplanted les
the dose would be increased 15% at each treatment interval
In the lesions of the other site of the body follicular grafts would be transplanted With FIT technique throughout the lesions. After 5 days dressings would removed. Two days later the lesional skin w
the dose increased 15% at each treatment interval

Sponsors

Vice chancellor for research of Skin and Stem cell Research Center of Tehran University of Medical S
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Patients diagnosed with stable; refractory vitiligo; No treatment in the last 6 months; depigmented patch more than 5 cm; ages between 12 and 60 years old. Exclusionary criteria included : pregnancy; lactation; hepatitis; HIV infection; active vitiligo; infection in the recipient site; history of photosensitivity or skin cancer; history of keloid healing; history of Kobner phenomenon.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Perifollicular repigmentation after treatment. Timepoint: 1 month, 2 months, 3 months after treatment. Method of measurement: Caliper, VETTI score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Feily

Skin and Stem cell Research Center of Tehran University of Medical Sciences

dr.feily@yahoo.com+98 21 2220 1710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026